| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |